SBEV Faces NYSE Delisting Risk, Pursues Medterra Merger to Restore Compliance
$SBEV received NYSE delisting notice for failing equity requirements; pursuing Medterra CBD merger to restore compliance by January 2027.
SBEVbalance sheetbusiness combination